Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy. On June 27, UBS kept its Buy rating ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Jury reaches partial verdict in Sean Combs trial, unable to reach verdict on Count One Republican Senator tells House not to ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

Making a dagger or giant knife fit for 2020 with a real murder hornet cast in epoxy resin. This project embodies a unique ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.